CIS

Clinical Immunology Society (CIS)

2017 Annual Meeting: Immune Deficiency and Dysregulation North American Conference

Continuing Medical Education

2017 Annual Meeting

Purpose

Provide an opportunity for physicians to receive updated information and solidify their knowledge of primary immune deficiency.

Content Area

The content will cover practical, cutting edge and theoretical issues related to patient care. The majority of immune deficiencies will be covered to provide the maximal educational experience.

Target Audience

Physicians, scientists and nurses who are involved in the evaluation and/or care of patients with primary immune deficiencies. Participants should be pediatricians, internists, or scientists committed to the clinical management of patients with primary immunodeficiency diseases. These candidates may have backgrounds in immunology, adult medicine, rheumatology, hematology, laboratory immunology, or allergy/immunology.

Learning Objectives

At the completion of the activity participants should be able to:

  • Recognize the value of new research techniques;
  • Describe new research findings in immunology;
  • Explain the diagnosis and management of diseases and disorders across various subspecialties of medicine.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Clinical Immunology Society designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Summer School, Second Edition: Cases and Controversies

PURPOSE

Provide an opportunity for physicians to update their knowledge of primary immune deficiency and have practical experience with real-life cases.

CONTENT AREA

The content will cover practical, cutting edge and theoretical issues related to patient care. Many types of immune deficiencies will be covered to provide the maximal educational experience.

TARGET AUDIENCE

Physicians, scientists and nurses who are involved in the evaluation and/or care of patients with primary immune deficiencies. Participants will pediatricians, internists, or scientists committed to the clinical management of patients with primary immune deficiency diseases. These candidates may have backgrounds in immunology, adult medicine, rheumatology, hematology, laboratory immunology, or allergy/immunology. This specific learning experience is targeted to those with significant clinical experience in the care of patients with primary immune deficiencies. Lab directors or others involved in diagnostic approaches would represent a key target group.  We will specifically encourage graduates of the CIS Summer School to attend to increase networking and to solidify their skill set.

LEARNING OBJECTIVES

Provide advanced training for physicians and researchers working in the field of primary immune deficiency that covers diagnosis, therapy and future trends related to the care of patients with primary immune deficiency.

  • Facilitate interactions among clinicians of diverse training to promote multicenter clinical trials and to coordinate participation in existing clinical trials.
  • Improve recognition of primary immune deficiencies.
  • Improve understanding of the diagnostic issues and the pathophysiology of primary immune deficiencies.
  • Improve understanding of the appropriate interventions for these diseases.

ACCME ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Clinical Immunology Society (CIS). The CIS is accredited by the ACCME to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The Clinical Immunology Society designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.